Stage I-II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy.

Michael S. Binkley,Susan M. Hiniker,Sheren F. Younes,Christopher H. Yoo,Anjali Wignarajah,Michael C. Jin,Haiwei H. Guo,Neel K. Gupta,Yasodha Natkunam,Ranjana H. Advani,Richard T. Hoppe

Stage I-II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy.

2021

Michael S. Binkley
Susan M. Hiniker
Sheren F. Younes
Christopher H. Yoo
Anjali Wignarajah
Michael C. Jin
Haiwei H. Guo
Neel K. Gupta
Yasodha Natkunam
Ranjana H. Advani
Richard T. Hoppe

We set to identify prognostic factors in a retrospective cohort of consecutive patients with stage I-II diffuse large B-cell lymphoma treated with rituximab-chemotherapy with or without radiotherap...

Keywords:

stage i ii
Oncology
Diffuse large B-cell lymphoma
Rituximab
Radiation therapy
Cytogenetics
Internal medicine
Retrospective cohort study
Medicine
Chemotherapy
Lymphoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations